BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 21894279)

  • 21. Adverse effects of proton pump inhibitors.
    Lodato F; Azzaroli F; Turco L; Mazzella N; Buonfiglioli F; Zoli M; Mazzella G
    Best Pract Res Clin Gastroenterol; 2010 Apr; 24(2):193-201. PubMed ID: 20227032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Review article: physiologic and clinical effects of proton pump inhibitors on non-acidic and acidic gastro-oesophageal reflux.
    Miner PB
    Aliment Pharmacol Ther; 2006 Mar; 23 Suppl 1():25-32. PubMed ID: 16483267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proton pump inhibitors for gastroduodenal damage related to nonsteroidal anti-inflammatory drugs or aspirin: twelve important questions for clinical practice.
    Arora G; Singh G; Triadafilopoulos G
    Clin Gastroenterol Hepatol; 2009 Jul; 7(7):725-35. PubMed ID: 19306941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proton Pump Inhibitors: What the Internist Needs to Know.
    Spechler SJ
    Med Clin North Am; 2019 Jan; 103(1):1-14. PubMed ID: 30466666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term safety concerns with proton pump inhibitors.
    Ali T; Roberts DN; Tierney WM
    Am J Med; 2009 Oct; 122(10):896-903. PubMed ID: 19786155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of use of proton pump inhibitors in Greece.
    Ntaios G; Chatzinikolaou A; Kaiafa G; Savopoulos C; Hatzitolios A; Karamitsos D
    Eur J Intern Med; 2009 Mar; 20(2):171-3. PubMed ID: 19327607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gastric acid suppressants--too much of a good thing?
    Logan IC; Sumukadas D; Witham MD
    Age Ageing; 2010 Jul; 39(4):410-1. PubMed ID: 20507846
    [No Abstract]   [Full Text] [Related]  

  • 28. Prescribing proton pump inhibitors for initial treatment of acid-related gastrointestinal diseases in a managed care population.
    Chan J; Hui RL; Szpakowski JL
    Am J Manag Care; 2004 Jul; 10(7 Pt 1):433-41. PubMed ID: 15298365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evidence and uncertainties on the clinical use of proton pump inhibitors].
    de Prados CM
    Gastroenterol Hepatol; 2010 May; 33 Suppl 1():5-10. PubMed ID: 20728783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Common gastrointestinal symptoms: risks of long-term proton pump inhibitor therapy.
    Fashner J; Gitu AC
    FP Essent; 2013 Oct; 413():29-39. PubMed ID: 24124705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Guide to the use of proton pump inhibitors in adult patients.
    Boparai V; Rajagopalan J; Triadafilopoulos G
    Drugs; 2008; 68(7):925-47. PubMed ID: 18457460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relationship among proton pump inhibitors, bone disease and fracture.
    Targownik LE; Leslie WD
    Expert Opin Drug Saf; 2011 Nov; 10(6):901-12. PubMed ID: 21599546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A safety review of proton pump inhibitors to treat acid-related digestive diseases.
    Savarino E; Marabotto E; Zentilin P; Furnari M; Bodini G; Pellegatta G; Lorenzon G; Della Coletta M; Ghisa M; Coppo C; Marinelli C; Savarino V
    Expert Opin Drug Saf; 2018 Aug; 17(8):785-794. PubMed ID: 30035645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors.
    Gerson LB; Boparai V; Ullah N; Triadafilopoulos G
    Aliment Pharmacol Ther; 2004 Sep; 20(6):637-43. PubMed ID: 15352912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Adverse effects of proton pump inhibitors: should we worry about long-term exposure?].
    Roulet L; Vernaz N; Giostra E; Gasche Y; Desmeules J
    Rev Med Interne; 2012 Aug; 33(8):439-45. PubMed ID: 22284952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deprescribing proton pump inhibitors.
    Turner JP; Thompson W; Reeve E; Bell JS
    Aust J Gen Pract; 2022 Nov; 51(11):845-848. PubMed ID: 36310001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vitamin B12 deficiency in hypersecretors during long-term acid suppression with proton pump inhibitors.
    Hirschowitz BI; Worthington J; Mohnen J
    Aliment Pharmacol Ther; 2008 Jun; 27(11):1110-21. PubMed ID: 18315582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proton pump inhibitor usage and the associated risk of pneumonia in patients with chronic kidney disease.
    Chen CH; Lin HC; Lin HL; Lin YT; Chou JM; Hsu SP; Fung CP
    J Microbiol Immunol Infect; 2015 Aug; 48(4):390-6. PubMed ID: 24291618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Review article: Helicobacter pylori and gastro-oesophageal reflux disease.
    Delaney B; McColl K
    Aliment Pharmacol Ther; 2005 Aug; 22 Suppl 1():32-40. PubMed ID: 16042657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proton pump inhibitors: use and misuse in the clinical setting.
    Savarino V; Marabotto E; Zentilin P; Furnari M; Bodini G; De Maria C; Pellegatta G; Coppo C; Savarino E
    Expert Rev Clin Pharmacol; 2018 Nov; 11(11):1123-1134. PubMed ID: 30295105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.